Credit Suisse Ag Puma Biotechnology, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.64 - $3.3 $27 - $56	17 New	17 $0
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $110,480 - $255,073	-38,765 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$6.63 - $9.39 $4,647 - $6,582	-701 Reduced 1.78%	38,765 $272,000
Q2 2021 Aug 16, 2021	BUY	$8.98 - $11.6 $6,178 - $7,980	688 Added 1.77%	39,466 $362,000
Q1 2021 May 14, 2021	SELL	$9.38 - $13.63 $389,795 - $566,408	-41,556 Reduced 51.73%	38,778 $376,000
Q4 2020 Feb 12, 2021	SELL	$7.78 - $12.13 $325,530 - $507,543	-41,842 Reduced 34.25%	80,334 $824,000
Q3 2020 Nov 13, 2020	SELL	$9.5 - $11.14 $420,954 - $493,624	-44,311 Reduced 26.62%	122,176 $1.23 Million
Q2 2020 Aug 12, 2020	BUY	$7.01 - $13.24 $259,790 - $490,674	37,060 Added 28.63%	166,487 $1.74 Million
Q1 2020 May 13, 2020	SELL	$6.28 - $14.57 $41,259 - $95,724	-6,570 Reduced 4.83%	129,427 $1.09 Million
Q4 2019 Feb 12, 2020	BUY	$6.5 - $10.73 $760,838 - $1.26 Million	117,052 Added 617.85%	135,997 $1.19 Million
Q3 2019 Nov 12, 2019	BUY	$8.75 - $12.85 $2,458 - $3,610	281 Added 1.51%	18,945 $204,000
Q2 2019 Aug 14, 2019	SELL	$12.3 - $35.76 $238,779 - $694,208	-19,413 Reduced 50.98%	18,664 $237,000
Q1 2019 May 14, 2019	SELL	$20.77 - $42.37 $749,859 - $1.53 Million	-36,103 Reduced 48.67%	38,077 $1.48 Million
Q4 2018 Feb 13, 2019	BUY	$20.07 - $46.7 $1.04 Million - $2.42 Million	51,869 Added 232.48%	74,180 $1.51 Million
Q3 2018 Nov 13, 2018	SELL	$41.2 - $59.85 $262,814 - $381,783	-6,379 Reduced 22.23%	22,311 $1.02 Million
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $157,844 - $223,041	-3,268 Reduced 10.23%	28,690 $1.7 Million
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $184,711 - $307,079	-3,094 Reduced 8.83%	31,958 $2.17 Million
Q4 2017 Feb 14, 2018	SELL	$93.85 - $132.45 $534,757 - $754,700	-5,698 Reduced 13.98%	35,052 $3.47 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $421,776 - $701,495	5,858 Added 16.79%	40,750 $4.88 Million
Q2 2017 Aug 14, 2017	BUY	N/A	34,892	34,892 $3.05 Million

Others Institutions Holding PBYI

# of Institutions

102

Shares Held

29M

Call Options Held

60.6K

Put Options Held

16.3K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$11.1 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$10.9 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$9.31 Million
0.42% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.88M
Shares

$8.76 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$5.99 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account